A Causal Role for Voltage-gated Cav1.2 Calcium Channels in Mediating 5G FR1 Effects on Sleep-associated Brain Health in Humans

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Mediation of 5G Effects on Sleep
Interventions
DRUG

Nimodipine Capsules

Two times 30 mg nimodipine or placebo will be administered orally 45 minutes prior to the start of the 5G FR1 exposure. The verum and placebo capsules will look the same, in order to preserve the double-blinding.

RADIATION

5G RF-EMF

Participants will be exposed to a standardized electromagnetic field of the latest mobile radio standard (5G) or a sham field for 30 minutes on each of the experimental nights. The active field is characterized by 3.6 GHz frequency \[TDD\] with 100 MHz bandwidth, 12-14 Hz modulation and is comparable to a phone call with a commercially available, modern cell phone. Both the 5G and sham exposures are performed with the same exposure apparatus, according to a double-blind study design.

Trial Locations (1)

8057

RECRUITING

University of Zurich, Institute of Pharmacology and Toxicology, Zurich

All Listed Sponsors
collaborator

Federal Office for the Environment, Switzerland

OTHER_GOV

lead

Hans-Peter Landolt

OTHER